(Reuters Health) – Globally, many countries don’t have enough donated blood to meet their needs, a recent study suggests. The World Health Organization (WHO) recommends that for every 1,000 people in any country, 10 to 20 blood donations are needed to provide ... More »
(Reuters) – Drug developer UniQure NV said on Friday its gene therapy to treat hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a small study. The company’s shares rose 5.5 percent in light premarket trading. The up... More »
(Reuters) – The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc’s Elzonris for the treatment of a rare blood disease in adults and children aged two years and above. This is the first approved treatment for the condition, blastic... More »
(Reuters) – The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc’s rare blood disorder drug Ultomiris, an early backing that also solidifies the company’s dominant market position. The company’s flagship drug, Soliris, was the l... More »
(Reuters Health) – Childhood cancer survivors who get plenty of vigorous exercise may live longer than their counterparts who aren’t very active, a recent study suggests. “In cancer survivors, cancer treatment causes what we consider to be an accelerated aging... More »
(Reuters Health) – Adult survivors of childhood cancer are at risk for serious chronic medical problems, but many of them are not particularly concerned about their future health, a study suggests. In a survey of 15,620 adult survivors of childhood cancer and ... More »
(Reuters Health) – Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs, a U.S. study suggests. Researchers examined data on payments drug companies made to doctors in 201... More »
By Lisa Rapaport(Reuters Health) – – People with severe symptoms of chronic fatigue syndrome have a molecular signature in their blood made up of 17 More »
CEO of Shire, Dr Flemming Ornskov, poses for a photograph in London, Britain, July 3, 2017. REUTERS/Peter Nicholls – RTS19MDH Pharmaceutical group Shire (SHP.L) said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche (ROG... More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to preven... More »
FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo U.S. drugmaker Pfizer Inc said on Wednesday it reached an agreement with Sangamo Therapeutics Inc for rights to its gene therapy program... More »
By Gene Emery(Reuters Health) – – Long-term follow-up of patients in a 2014 study confirms that stroke patients recover better if doctors physically More »
A diabetic applies an Insulin pen injection in Vienna November 13, 2012. REUTERS/Heinz-Peter Bader By Lisa Rapaport(Reuters Health) – – Adults with type 1 diabetes may be able to manage their blood sugar levels just as well with multiple daily insu More »
By Andrew M. Seaman(Reuters Health) – When the human immunodeficiency virus (HIV) is successfully suppressed by medication, people with HIV can’t tr More »
By Will Boggs MD(Reuters Health) – A genetic trait that affects red blood cells and is fairly common among African Americans and Hispanic Americans c More »
By Andrew M. Seaman(Reuters Health) – Drugs recently approved around the world to fight cancer increased patients’ overall survival, but benefits va More »
By Lisa Rapaport(Reuters Health) – – Men may have an increased risk of blood clots after they start taking testosterone to treat sexual dysfunction, More »
U.S. states must do more to ensure that all children enrolled in the Medicaid health care program are tested for lead poisoning, a U.S. Government agency said this week, acknowledging major gaps in screening that were highlighted in a recent Reuters investigat... More »
By Lisa Rapaport(Reuters Health) – – Children who’ve had cancer may be more likely to receive the follow-up care they need in adulthood if their pare More »
By Lisa Rapaport(Reuters Health) – Despite advances that have made treatments safer and more effective, childhood cancer survivors don’t appear to ha More »
Roche tablets are seen in this photo illustration shot in Zenica, Bosnia and Herzegovina, January 18, 2016. REUTERS/Dado Ruvic/File Photo Four patients have suffered serious adverse events in a clinical trial of an experimental hemophilia medicine from Roche, ... More »
(Reuters Health) – U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a rece... More »
RIO DE JANEIRO The worst health scare in recent history is not keeping Brazilians from their annual Carnival revelry, with millions of partiers swarming streets and some making fun of the mosquito that spreads Zika and other viruses. Street processions, block ... More »
The U.S. Food and Drug Administration said on Friday it approved Baxalta Inc’s drug for use in patients with a type of rare bleeding disorder. The drug, Adynovate, was approved to control and reduce the frequency of bleeding episodes in patients with Hemophili... More »
LONDON Three of Europe’s top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. The unusual confluence of investor days comes at a testing time ... More »
We use cookies!
By using this site you agree to the use of cookies, more info.